Tonb Dalal, Mehta Raj, Wang Hugh, Tung John, Mehta Devendra I
Alfred I. duPont Hospital for Children, Wilmington, Delaware 19899, USA.
Dig Dis Sci. 2003 Aug;48(8):1614-8. doi: 10.1023/a:1024780226875.
Epidermal growth factor (EGF) up-regulation of glucose absorption via increased Na+/glucose co-transporter (SGLT-1) activity has previously been described in rabbit jejunal brush-border membrane and in differentiated Caco-2 cells. The goal of the present study was to assess the in vitro effect of EGF (200 ng/ml) on glucose uptake in human mucosal specimens, and we describe a simple procedure that uses endoscopic biopsies for short-term gludose uptake measurements. Uptake values for the EGF-treated biopsies ranged from 2.7 to 29.0, with a mean uptake of 10.65, while uptake values for the untreated biopsies ranged from 0.9 to 17.5, with a mean uptake of 7.99 (P < 0.05, paired t test). This early effect of EGF on human enterocytes may have important therapeutic implications. A role in increasing the rate of internal rehydration is suggested.
表皮生长因子(EGF)通过增加钠/葡萄糖共转运体(SGLT-1)的活性来上调葡萄糖吸收,此前已在兔空肠刷状缘膜和分化的Caco-2细胞中得到描述。本研究的目的是评估EGF(200 ng/ml)对人体黏膜标本中葡萄糖摄取的体外作用,并且我们描述了一种使用内镜活检进行短期葡萄糖摄取测量的简单方法。经EGF处理的活检标本的摄取值范围为2.7至29.0,平均摄取值为10.65,而未经处理的活检标本的摄取值范围为0.9至17.5,平均摄取值为7.99(配对t检验,P < 0.05)。EGF对人肠上皮细胞的这种早期作用可能具有重要的治疗意义。提示其在提高体内补液速率方面发挥作用。